Alexandria Venture Investments, LLC
SEC CIK 1722024 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| XLO | Xilio Therapeutics, Inc. | 10% | 166.4K | — | — | 1 | 2021-10-26 | 2021-10-26 |
Most active insiders at XLO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Shannon James Samuel | Dir | $43.9K | — |
| 2 | Frankenfield Christopher James | CFO | — | $4,499 |
| 3 | Brennan Kevin M. | SVP, Fin AND ACCOUNTING | — | $1,169 |
| 4 | Luptakova Katarina | Chief MEDICAL Off | — | — |
| 5 | Russo Rene | Pres AND CEO, Dir | — | — |
Alexandria Venture Investments, LLC made no open-market trades at XLO in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-26 | 2021-10-26 | XLO | Xilio Therapeutics, Inc. | Alexandria Venture Investments, LLC | 10% | C - Cnv Deriv | — | +166.4K | 166.4K | New | — |
Purchase Sale Sale after option exercise All abbreviations